Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 2
2014 2
2015 2
2016 1
2018 1
2019 3
2020 3
2021 1
2022 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Results by year

Filters applied: . Clear all
Page 1
Clonal hierarchy of main molecular lesions in acute myeloid leukaemia.
Herudkova Z, Culen M, Folta A, Jeziskova I, Cerna J, Loja T, Tom N, Smejkal J, Semerad L, Dvorakova D, Mayer J, Racil Z. Herudkova Z, et al. Among authors: folta a. Br J Haematol. 2020 Aug;190(4):562-572. doi: 10.1111/bjh.16341. Epub 2019 Dec 10. Br J Haematol. 2020. PMID: 31822038 Free article.
Single and multiple point NRAS mutations in acute myeloid leukemia: a study of 327 well molecularly characterized patients.
Durinikova A, Folta A, Pardy F, Svaton J, Drncova M, Weinbergerova B, Cetkovsky P, Racil Z, Jindra P, Szotkowski T, Zak P, Mayer J, Jeziskova I. Durinikova A, et al. Among authors: folta a. Leuk Lymphoma. 2022 Dec;63(13):3237-3240. doi: 10.1080/10428194.2022.2116931. Epub 2022 Sep 1. Leuk Lymphoma. 2022. PMID: 36047997 No abstract available.
A validation study of potential prognostic DNA methylation biomarkers in patients with acute myeloid leukemia using a custom DNA methylation sequencing panel.
Šestáková Š, Cerovská E, Šálek C, Kundrát D, Ježíšková I, Folta A, Mayer J, Ráčil Z, Cetkovský P, Remešová H. Šestáková Š, et al. Among authors: folta a. Clin Epigenetics. 2022 Feb 11;14(1):22. doi: 10.1186/s13148-022-01242-6. Clin Epigenetics. 2022. PMID: 35148810 Free PMC article.
Prognostic significance of mutation profile at diagnosis and mutation persistence during disease remission in adult acute myeloid leukaemia patients.
Folta A, Culen M, Jeziskova I, Herudkova Z, Tom N, Hlubinkova T, Janeckova V, Durinikova A, Vydra J, Semerad L, Dvorakova D, Remesova H, Cerovska E, Cetkovsky P, Jindra P, Szotkowski T, Zak P, Mayer J, Racil Z. Folta A, et al. Br J Haematol. 2019 Jul;186(2):300-310. doi: 10.1111/bjh.15916. Epub 2019 Apr 9. Br J Haematol. 2019. PMID: 30968396 Free article. Clinical Trial.
Why are not all eligible chronic myeloid leukemia patients willing to attempt tyrosine kinase inhibitor discontinuation? A Czech nationwide analysis related to the TKI stopping trial HALF.
Žáčková D, Semerád L, Faber E, Klamová H, Stejskal L, Bělohlávková P, Karas M, Cmunt E, Černá O, Procházková J, Čičátková P, Kvetková A, Horňák T, Skoumalová I, Srbová D, Šálek C, Buffa D, Voglová J, Jurček T, Folta A, Ježíšková I, Žižková H, Machová Poláková K, Papajík T, Žák P, Jindra P, Svobodník A, Štěpánová R, Mayer J. Žáčková D, et al. Among authors: folta a. Leukemia. 2024 Apr;38(4):893-897. doi: 10.1038/s41375-024-02215-9. Epub 2024 Mar 12. Leukemia. 2024. PMID: 38472478 Free PMC article. No abstract available.
16 results